載入...
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy
BACKGROUND: Neoadjuvant folinic acid, fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) and chemoradiation have been used to downstage borderline and locally advanced pancreatic ductal adenocarcinoma (PDAC). Whether neoadjuvant therapy-induced tumor immune response contributes to the improved s...
Na minha lista:
| 發表在: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7850539/ https://ncbi.nlm.nih.gov/pubmed/32497200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djaa073 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|